These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of halofenate and clofibrate on lipid synthesis in rat adipocytes. Greenspan MD; Germershausen JI; Mackow R Biochim Biophys Acta; 1975 Feb; 380(2):190-8. PubMed ID: 1120140 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of halofenate (MK-185) and clofibrate on plasma lipid and uric acid concentration in hyperlipoproteinemic patients. Lisch HJ; Patsch J; Sailer S; Braunsteiner H Atherosclerosis; 1975; 21(3):391-9. PubMed ID: 1148032 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of clofibrate and halofenate (MK-185) in isolated rat hepatocytes. Homcy CJ; Margolis S Atherosclerosis; 1974; 19(3):381-91. PubMed ID: 4828566 [No Abstract] [Full Text] [Related]
5. Halofenate and clofibrate inhibition of pyruvate dehydrogenase from Fusarium culmorum. Madhosingh C; Orr W J Environ Sci Health B; 1985 Apr; 20(2):201-14. PubMed ID: 3998411 [TBL] [Abstract][Full Text] [Related]
6. Effects of halofenate on glucose tolerance in patients with hyperlipoproteinemia. Feldman EB; Gluck FB; Carter AC J Clin Pharmacol; 1978; 18(5-6):241-8. PubMed ID: 346616 [TBL] [Abstract][Full Text] [Related]
7. The effect of halofenate and clofibrate on aggregation and release of serotonin by human platelets. Lin CY; Smith S Life Sci; 1976 Mar; 18(6):563-8. PubMed ID: 1263738 [No Abstract] [Full Text] [Related]
8. The effect of halofenate or halofenate free acid on human, rat and guinea pig platelet aggregation. Minsker DH; Jordan PT; Kling P; MacMillan A; Hucker HB Thromb Haemost; 1976 Apr; 35(2):358-63. PubMed ID: 989636 [TBL] [Abstract][Full Text] [Related]
9. The metabolic spectrum of halofenate. Ryan JR Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):239-43. PubMed ID: 51838 [TBL] [Abstract][Full Text] [Related]
10. Studies on the mechanism of action of halofenate. Mandel LR Lipids; 1977 Jan; 12(1):34-43. PubMed ID: 319318 [TBL] [Abstract][Full Text] [Related]
11. Halofenate: a potent inhibitor of normal and hypersensitive platelets. Colman RW; Bennett JS; Sheridan JF; Cooper RA; Shattil SJ J Lab Clin Med; 1976 Aug; 88(2):282-91. PubMed ID: 956686 [TBL] [Abstract][Full Text] [Related]
12. Halofenate and clofibrate: mechanism of hypotriglyceridemic action in the rat. Cenedella RJ; Crouthamel WG J Lipid Res; 1976 Mar; 17(2):156-66. PubMed ID: 1270931 [TBL] [Abstract][Full Text] [Related]
14. Effect of halofenate and clofibrate on growth and lipid synthesis in Saccharomyces cerevisiae. Greenspan MD; Germershausen JI J Bacteriol; 1973 Feb; 113(2):847-55. PubMed ID: 4570609 [TBL] [Abstract][Full Text] [Related]
15. Effect of clofibrate on the handling of dietary and liver fat. Westerfeld WW; Elwood JC; Richert DA Biochem Pharmacol; 1972 Apr; 21(8):1117-25. PubMed ID: 5034197 [No Abstract] [Full Text] [Related]
16. Potentiation of hypoglycemic effect of sulfonylureas by halofenate. Jain AK; Ryan JR; McMahon FG N Engl J Med; 1975 Dec; 293(25):1283-6. PubMed ID: 171574 [TBL] [Abstract][Full Text] [Related]
17. Studies on the mechanism of inhibition of acute alcoholic fatty liver by clofibrate. Kähönen MT; Yilkahri RH; Hassinen I Metabolism; 1972 Nov; 21(11):1021-8. PubMed ID: 5080087 [No Abstract] [Full Text] [Related]
18. Long-term efficacy of halofenate on serum triglyceride levels. Aronow WS; Vicario MD; Moorthy K; King J; Vawter M; Papageorge's NP Curr Ther Res Clin Exp; 1975 Dec; 18(6):855-61. PubMed ID: 813950 [No Abstract] [Full Text] [Related]
19. Comparison of clofibrate with halofenate in diabetics with hyperlipidaemia. Krut LH; Seftel HC; Joffe BI S Afr Med J; 1977 Mar; 51(11):348-52. PubMed ID: 323994 [TBL] [Abstract][Full Text] [Related]
20. The immediate and long term effects of clofibrate on the metabolism of the perfused rat liver. Laker ME; Mayes PA Biochem Pharmacol; 1979 Sep; 28(18):2813-27. PubMed ID: 497030 [No Abstract] [Full Text] [Related] [Next] [New Search]